Article
Gene correction and overexpression of TNNI3 improve impaired relaxation in engineered heart tissue model of pediatric restrictive cardiomyopathy.
Development, growth & differentiation - 1 Feb 2024
Hasegawa Moyu, Miki Kenji, Kawamura Takuji, Takei Sasozaki Ikue, Higashiyama Yuki, Tsuchida Masaru, Kashino Kunio, Taira Masaki, Ito Emiko, Takeda Maki, Ishida Hidekazu, Higo Shuichiro, Sakata Yasushi, Miyagawa Shigeru
Abstract excerpt
Research on cardiomyopathy models using engineered heart tissue (EHT) created from disease-specific induced pluripotent stem cells (iPSCs) is advancing rapidly. However, the study of restrictive cardiomyopathy (RCM), a rare and intractable cardiomyopathy, remains at the experimental stage because there is currently no established method to replicate the hallmark phenotype of RCM, particularly diastolic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
